middle.news
Island Pharmaceuticals Unveils FDA Insights on Galidesivir Approval Pathway
2:52pm on Thursday 13th of November, 2025 AEDT
•
Healthcare
Read Story
Island Pharmaceuticals Unveils FDA Insights on Galidesivir Approval Pathway
2:52pm on Thursday 13th of November, 2025 AEDT
Key Points
Webinar scheduled for 17 November 2025 featuring CEO Dr David Foster and Chairman Jason Carroll
Discussion on FDA's response to Type C Meeting Request regarding Galidesivir's development
Focus on use of FDA's Animal Rule and Priority Review Voucher eligibility
Plans for a proposed animal study targeting Marburg virus
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ILA
OPEN ARTICLE